Objective To investigate the relationship between prognostic nutritional index (PNI) and treatment failure in patients with peritoneal dialysis-associated peritonitis (PDAP). Methods A total of 205 PDAP patients hospitalized in the Department of Nephrology from January 2016 to August 2024 were enrolled. Based on treatment outcomes, patients were divided into a cured group (n=170) and a treatment failure group (n=35). Clinical data were compared between the two groups. Results Compared with the cured group, the treatment failure group had longer dialysis vintage (Z=-3.422, P=0.001), higher peritoneal effluent white blood cell (WBC) count on day 3 (Z=-5.219, P＜0.001),higher levels of C-reactive protein (CRP) (Z= -3.044, P=0.002) , but lower body mass index (BMI) (Z=-2.032, P=0.042) and PNI (t=6.707, P＜0.001). Univariate logistic regression analysis showed that self-administered antibiotic use before admission (OR =4.592, 95% CI:2.118～9.957, P＜0.001), longer dialysis vintage (OR=1.250, 95% CI:1.105～1.414, P＜0.001), higher day 3 peritoneal effluent WBC count (OR=1.021, 95% CI:1.007～1.035, P=0.003), higher CRP (OR= 1.006, 95% CI:1.002～1.010, P=0.002), lower BMI (OR =0.886, 95% CI:0.796～0.987, P=0.028), and lower PNI (OR=0.833, 95% CI:0.771～0.898, P＜0.001) were risk factors for treatment failure in PDAP patients. Multivariate logistic regression analysis confirmed that longer dialysis vintage (OR=1.179, 95% CI:1.018～1.363, P=0.027), higher day 3 WBC count (OR=1.028, 95% CI:1.010～1.046, P=0.002), and lower PNI (OR=0.853, 95% CI :0.771～0.937, P=0.001) were independent risk factors for treatment failure. Receiver operating characteristic (ROC) curve analysis showed that PNI had the highest predictive value for treatment failure (AUC=0.776), and its predictive performance further improved when combined with dialysis vintage (AUC=0.816). Conclusion PNI reflects the nutritional and immune status of the body and is associated with PDAP treatment failure. It demonstrates good predictive ability for treatment outcomes, and its predictive power increases when combined with dialysis vintage.
ZHANG Jin-Jin
,
MA Ya-Nan
,
YAN Qi-Qi
,
LI Dan-Dan
,
CHEN Xiao-Li
,
LIU Gui-Ling
. Exploration of the relationship between prognostic nutritional index and treatment failure in peritoneal dialysis related peritonitis patients[J]. Chinese Journal of Blood Purification, 2025
, 24(07)
: 566
-570
.
DOI: 10.3969/j.issn.1671-4091.2025.07.005
[1] Bello A K, Levin A, Lunney M, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey [J]. BMJ, 2019, 367: l5873.
[2] Cho Y, Htay H, Johnson D W. Centre effects and peritoneal dialysis-related peritonitis [J]. Nephrol Dial Transplant, 2017, 32(6): 913-915.
[3] Shah A D, Vashisth S, Raker C A, et al. Trends, Outcomes, and Economic Implications of Peritoneal Dialysis-Associated Peritonitis Hospitalizations: A National Cohort Study [J]. Am J Nephrol, 2024, 55(4): 472-476.
[4] Kim Y J, Park H P, Kim H S, et al. Preoperative Prognostic Nutritional Index Is a Prognostic Indicator of Cancer-Specific Survival in Patients Undergoing Endometrial Cancer Surgery [J]. J Korean Med Sci, 2023, 38(21): e163.
[5] Zencirkiran Agus H, Kahraman S. Prognostic nutritional index predicts one-year outcome in heart failure with preserved ejection fraction [J]. Acta Cardiol, 2020, 75(5): 450-455.
[6] Wei W, Wu X, Jin C, et al. Predictive Significance of the Prognostic Nutritional Index (PNI) in Patients with Severe COVID-19 [J]. J Immunol Res, 2021, 2021: 9917302.
[7] Lee Y F, Lin P R, Wu S H, et al. Impact of the prognostic nutritional index on renal replacement therapy-free survival and mortality in patients on continuous renal replacement therapy [J]. Ren Fail, 2024, 46(2): 2365394.
[8] Yu J H, Chen Y, Yin M G. Association between the prognostic nutritional index (PNI) and all-cause mortality in patients with chronic kidney disease [J]. Ren Fail, 2023, 45(2): 2264393.
[9] Zhang J, Chen Y, Zou L, et al. Prognostic nutritional index as a risk factor for diabetic kidney disease and mortality in patients with type 2 diabetes mellitus [J]. Acta Diabetol, 2023, 60(2): 235-245.
[10] Li P K, Chow K M, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment [J]. Perit Dial Int, 2022, 42(2): 110-153.
[11] Baralic M, Spasojevic I, Miljus G, et al. Albumin at the intersection between antioxidant and pro-oxidant in patients on peritoneal dialysis [J]. Free Radic Biol Med, 2022, 187: 105-112.
[12] Liu L, Xie K, Yin M, et al. Serum potassium, albumin and vitamin B(12) as potential oxidative stress markers of fungal peritonitis [J]. Ann Med, 2021, 53(1): 2132-2141.
[13] McMillan D C. Systemic inflammation, nutritional status and survival in patients with cancer [J]. Curr Opin Clin Nutr Metab Care, 2009, 12(3): 223-226.
[14] Wang X, Han Q, Wang T, et al. Serum albumin changes and mortality risk of peritoneal dialysis patients [J]. Int Urol Nephrol, 2020, 52(3): 565-571.
[15] He Y, Huang X, Zhang J, et al. Decreased Peripheral Blood Lymphocyte Count Predicts Poor Treatment Response in Peritoneal Dialysis-Associated Peritonitis [J]. J Inflamm Res, 2023, 16: 5327-5338.
[16] Liang Q, Zhao H, Wu B, et al. Effect of different dialysis duration on the prognosis of peritoneal dialysis-associated peritonitis: a single-center, retrospective study [J]. Ren Fail, 2023, 45(1): 2177496.
[17] Su Y J, Liao S C, Cheng B C, et al. Increasing high-sensitive C-reactive protein level predicts peritonitis risk in chronic peritoneal dialysis patients [J]. BMC Nephrol, 2013, 14: 185.
[18] Zalunardo N Y, Rose C L, Ma I W, et al. Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis [J]. Kidney Int, 2007, 71(7): 687-692.
[19] Keskin G?zmen ?, Serdaro?lu E. High C-reactive protein and number of previous episodes at diagnosis increase the risk of catheter removal in peritoneal dialysis-related peritonitis in children [J]. Ther Apher Dial, 2023, 27(2): 328-334.
[20] Intarasupht J, Kanchanomai A, Leelasattakul W, et al. Prevalence, risk factors, and mortality outcome in the drug reaction with eosinophilia and systemic symptoms patients with cardiac involvement [J]. Int J Dermatol, 2018, 57(10): 1187-1191.
[21] Lonardo M S, Cacciapuoti N, Chiurazzi M, et al. Combined use of handgrip strength and hemoglobin as markers of undernutrition in patients with stage 3-5 chronic kidney disease [J]. Nutr Metab Cardiovasc Dis, 2023, 33(11): 2169-2178.
[22] Fu S, Huang J, Feng Z, et al. Inflammatory indexes and anemia in chronic kidney disease: correlation and survival analysis of the National Health and Nutrition Examination Survey 2005-2018 [J]. Ren Fail, 2024, 46(2): 2399314.
